Adam has a unique background with a wealth of experience as both a senior Healthcare executive and a Wall Street veteran. He has over 20 years of experience working with many of the leading Healthcare Services companies. He is the Chairman of the Board at HealthChannels (ScribeAmerica), the nation’s leading provider of medical scribes and solutions. He also currently serves on the Board of Directors at PathGroup, a leading pathology services company, Imedex, the leading provider of accredited continuing medical education (CME) for oncologists, Surgery Partners (NASDAQ: SGRY), a leading surgery center and physician services organization and Quorum Healthcare Corporation (NYSE: QHC), a rural hospital operator.
Prior to founding VSCP, he was the Senior Vice President of Corporate Development, Strategic Planning and Office of the CEO at Laboratory Corporation of America Holdings (LabCorp) where he oversaw M&A, Corporate Development, Strategic Partnerships and Corporate Strategy and managed the company’s partnerships with large Hospital Systems. He also created the LabCorp private equity investment vehicle.
Prior to LabCorp, Adam was the Managing Director in Equity Research at Barclays Capital/Lehman Brothers for 14 years, where he covered, as well as coordinated, the firm's Health Care Facilities and Services research teams. He was ranked #1 in the Institutional Investor All America Research Survey in the Health Care Facilities category, for a decade and was considered the best Healthcare Services analyst on Wall Street. He covered many of the top Healthcare organizations and completed capital market transactions for companies, including HCA, Team Health, Psychiatric Solutions, Universal Health Services, Tenet Healthcare, United Surgical Partners, AmSurg and Vanguard Health Services.
Mr. Feinstein is a CFA charterholder and has a B.S. in Business from the Smith School at the University of Maryland at College Park. He also completed the Nashville Healthcare Council Fellows program.
Larry joined the Vesey Street team, bringing his long background and experience both as a senior Healthcare executive and a Wall Street veteran. Larry has been in the Healthcare industry for close to 30 years and created the Healthcare Services team at Lehman Brothers with Mr Feinstein close to 20 years ago. He is currently a member of the Board of Directors at HealthChannels and Imedex. Prior to his joining VSCP, he was Executive Vice President of New Market Development and Chief Strategy Officer at AmerisourceBergen, a Fortune 15 pharmaceutical and Healthcare services organization. While there, the company completed over 30 M&A transactions that represented in excess of $7 billion in capital.
Prior to AmerisourceBergen, Larry was the Managing Director in Equity Research at Barclays Capital/Lehman Brothers, where he covered and coordinated the Healthcare Distribution & Technology segment. He was ranked #1 in the Institutional Investor All America Research Survey in that category for nine years and was considered a leading voice on Wall Street. He received his Master of Public Health degree from Columbia University, as well as his MBA and BS from the University of Richmond.
Dan joined Vesey Street Capital Partners in 2014 and serves as a General Partner for the firm. In addition to sourcing and evaluating potential investment opportunities, Dan with works closely with VSCP's portfolio companies and is a Board Member of Imedex as well as a Board Observer of HealthChannels.
Prior to joining Vesey Street, Dan worked with Adam, Larry, and Joe at Barclays Capital as a Vice President and Research Analyst focusing on the Healthcare Facilities and Medical Supplies & Devices Sectors. Dan has worked with the Vesey Street team since joining the group at Lehman Brothers in 2007.
Dan received a B.S. in Management Science from the University of California – San Diego and is a CFA charterholder.
Joe joined Vesey Street Capital Partners in 2014 and is a General Partner for the firm. Joe is intimately involved with each portfolio company and is responsible for evaluating new investment opportunities. Additionally, Joe serves as a Board Observer for HealthChannels and Imedex.
Prior to joining Vesey Street, Joe was a Research Analyst at S.A.C. Capital, where he was responsible for Healthcare Services investments across a $500 million Healthcare-dedicated portfolio. His sector mandate encompassed over 100 Healthcare Services companies, ranging from Hospitals and Post-Acute care to Healthcare Technology and Digital Health. Prior to his time at S.A.C., Joe worked with Adam, Larry and Dan at Barclays Capital, focusing on the Managed Care sector. Overall, Joe has over eight years of experience covering the Healthcare Services sector.
Joe received a B.A. in History from Georgetown University where he was a member of the Division I-AA football team, and an M.B.A. from Columbia Business School.
David joined Vesey Street Capital Partners in 2016 as a General Partner from Morgan Stanley, where he was a Managing Director and head of US institutional equity sales in New York and other regions and several other businesses within US equities. Morgan Stanley's equity sales effort was consistently top-ranked in industry polls during his tenure. He worked closely with other members of the VSCP team over many years at Lehman Brothers, where he was a Managing Director in US institutional equity sales and received the firm's Chairman Award three times. David was a corporate litigation associate at Simpson Thacher & Bartlett and senior aide to United States Senator Daniel Patrick Moynihan in Washington.
David is Vice Chairman of the Board of Trustees of the Winterthur Museum (Wilmington, DE), the nation's largest museum for American decorative arts, and chairs the Investment Committee. He is also a trustee of Weantinoge Heritage Land Trust, Connecticut's largest land trust. He holds a BA from Brown University, where he was elected to Phi Beta Kappa, an MSc from the London School of Economics, and a JD from Columbia Law School. David received the Saint David's School Alumnus of the Year Award in 2012.
Bryan joined Vesey Street Capital Partners in 2016 and is the Chief Financial Officer of the firm. Prior to joining VSCP, Bryan Sekino worked at Brant Point Capital Management, where he was responsible for healthcare investments across a diversified portfolio. He was also an analyst at Lehman Brothers and Barclays Capital working with Adam, Larry, Dan and Joe and focusing on the Healthcare Facilities sector. Overall, Bryan has over nine years of experience covering the Healthcare Services sector. Prior to his time as a research analyst, Bryan also spent four years working in operations at Lehman Brothers.
Bryan is a CFA charterholder and received a B.A. from The University of Michigan and an M.B.A. from Columbia Business School.
Chairman – VSCP Strategic Advisory Board
Jay is Chairman of the VSCP Strategic Advisory Board. Mr. Flaherty is former Managing Partner of NorthStar Healthcare Finance (NYSE:NRF). Prior to joining NorthStar, Mr. Flaherty was the Chairman and CEO of HCP, Inc., from 2003 to 2013 (NYSE: HCP). During his tenure at HCP, Mr. Flaherty grew HCP's equity market capitalization tenfold, from approximately $2 billion in 2003 to over $20 billion in 2013, becoming the third largest REIT in the United States, the first healthcare REIT selected to the S&P 500 and the only REIT in the world selected to the S&P 500 "Dividend Aristocrats" Index. During Mr. Flaherty's tenure at HCP, average shareholder returns exceeded 15% per year.
Prior to joining HCP, Mr. Flaherty served at Merrill Lynch & Co. for 19 years in a variety of investment banking, capital markets and private equity functions in New York, London, Los Angeles and was head of Merrill Lynch's Global Healthcare Group, where he established and led Merrill Lynch’s healthcare franchise. Throughout his career with Merrill Lynch, Mr. Flaherty developed significant corporate finance and mergers and acquisitions expertise along with substantial relationships with senior healthcare executives. In addition, from 1995 to 2001, Mr. Flaherty was a member of Merrill Lynch’s Investment Banking Operating Committee. Mr. Flaherty was associated with the accounting firm of Ernst & Whinney in its Boston office from 1979 to 1981 where he was a Certified Public Accountant.
Mr. Flaherty has served on the Board of Directors of Quest Diagnostics (NYSE: DGX), a leading national provider of diagnostic testing, information and services. From 1991-2001, Mr. Flaherty served as a member of the Board of Trustees at St. John’s Hospital and Health Center in Santa Monica, California. Mr. Flaherty received a BBA in accounting from the University of Notre Dame and earned an M.B.A. from the Graduate School of Management at the University of California, Los Angeles.
Mr. Cash is a member of the board of HealthChannels (ScribeAmerica). He was Chief Financial Officer of CHS/Community Health Systems, Inc. from 1997 until 2017 and was elected to the board of directors in 2001. In addition, Larry served as President of Financial Services and CFO from 2014 to 2017. He oversaw all aspects of Community Health Systems’ financial operations, including accounting, financial services, revenue management and treasury. For 11 consecutive years, Institutional Investor magazine named Mr. Cash one of the Top Three Chief Financial Officers in the Healthcare Industry.
He served as Vice President and Group Chief Financial Officer of Columbia/HCA Healthcare Corporation from 1996 to 1997. He spent 23 years at Humana, and served as its Senior Vice President of Finance and Operations from 1993 to 1996. He has been a director of Cross Country Healthcare (formerly Cross Country, Inc.) since 2001. He served as a Director of Quorum Health Corporation until 2016.
Mr. Cash is a graduate of the University of Kentucky.
Mr. Geiser serves on the board of Imedex. Mr. Geiser has served as advisor and legal counsel to numerous healthcare organizations with a focus on healthcare financing and delivery. Mr. Geiser served as the Executive Vice President and General Counsel of WellPoint Health Networks from its inception in 1993 until 2005. As WellPoint’s chief counsel, he was involved in all of the company’s mergers and acquisitions and in its numerous public securities offerings. He was responsible for WellPoint’s legal, legislative and regulatory affairs in 50 states and served as its principal contact with state and federal regulators. He was also responsible for all of the company’s litigation, including the litigation of its affiliated Blue Cross and Blue Shield plans and health insurance companies.
Prior to joining WellPoint, Mr. Geiser spent 15 years as an attorney in private law practice at Brobeck, Phleger & Harrison in San Francisco, California. He was also a partner in Epstein, Becker, Stromberg & Green and in Hanson, Bridgett, Marcus, Vlahos & Stromberg in San Francisco. He has been elected to Best Lawyers in America and was named to 100 Most Influential Attorneys in California by California Law Business. He is a member of the Board of Directors of Surgical Care Affiliates, IASIS Healthcare Corporation, Imedex Holdco LLC, Providence Saint John's Health Center and the Library Foundation of Los Angeles. He is also a member of the Advisory Board of the Stanford University Institute for Research in the Social Sciences.
Mr. Geiser is a Senior Advisor to TPG Capital, a private investment firm with more than $65 billion of capital under management. Mr. Geiser received his J.D. from the University of California, Hastings College of the Law and his undergraduate degree from the University of Redlands.
Mr. Geringer serves as Chairman of Imedex. He is an experienced and accomplished healthcare services executive and entrepreneur with a record of success in hospital management; managed care; pharmaceutical distribution; and, various provider services companies. He has founded, served as CEO and/or director of a number of public and private healthcare companies.
Mr. Geringer is immediate past Chairman of AmSurg Corporation which merged in 2016 with Envision Healthcare which he now serves as a Director. He also serves as Chairman of Addus HomeCare and as a Director of MedEquities Realty Trust, both of which are public companies, as well as a director of several privately-held healthcare companies. At Alvarez & Marsal, LLC, he served as Managing Director and Co-Practice Leader of Healthcare Industry Private Equity from 2013 to 2015.
Mr. Geringer holds a B.S. in economics from The Wharton School of the University of Pennsylvania. He resides in Nashville.
Mr. Safreno spent 20 years working for two investment banks in the New York and San Francisco areas, including 10 years as these firm's Global Head of Healthcare Investment Banking. From 1988 through mid-2003, Mr. Safreno was with Merrill Lynch & Co. in New York and San Francisco and was Global Head of the firm's Healthcare Investment Bank from 1999-2003. From mid-2003 through 2007, he was with Lehman Brothers, Inc. in New York and San Francisco as Global Head of the firm's Healthcare Investment Bank.
At these firms, he was responsible for managing the global healthcare investment banking business, as well as directly advising on numerous transactions involving many of the largest healthcare companies in the United States and Europe, including pharmaceutical and biotechnology firms such as Roche, Pfizer, Johnson & Johnson, Eli Lilly, and Amgen and healthcare services firms such as Anthem, United Heathcare, HCA, Tenet, and Aetna.
Over the last several years Mr. Safreno has developed a sizable agricultural real estate enterprise, primarily located in California. He has an MBA from Stanford Graduate School of Business (Arjay Miller Scholar), a JD from Harvard Law School and an AB in Economics from Stanford University.
Mr. Schaeffer is the founding Chairman & CEO of WellPoint, the nation’s largest health benefits company by membership. WellPoint (now Anthem) serves over 39 million medical members and has annualized revenues of $85 billion. He is currently the Judge Robert Maclay Widney Chair and Professor at the University of Southern California and is a Senior Advisor to TPG Capital, a private equity firm. Mr. Schaeffer was Chairman & CEO of WellPoint from 1992 through 2004 and continued to serve as Chairman through 2005. Under his leadership, WellPoint was selected by FORTUNE magazine as America’s “Most Admired Health Care Company” for six consecutive years; named by BusinessWeek as one of the 50 best performing public companies for three consecutive years; and identified by Forbes magazine as America’s best large health insurance company. Schaeffer was selected by BusinessWeek magazine as one of the “Top 25 Managers of the Year” and by Worth magazine as one of the “50 Best CEOs in America.” In 1986, Schaeffer was recruited as CEO to WellPoint’s predecessor company, Blue Cross of California, when it was near bankruptcy. He managed the turnaround of Blue Cross of California and the IPO creating WellPoint in 1993. During his tenure, WellPoint made 17 acquisitions and endowed four charitable foundations with assets of over $6 billion. Under Schaeffer’s leadership, WellPoint’s value grew from $11 million to over $49 billion.
In 2009, Mr. Schaeffer established a new research center at USC. The Schaeffer Center for Health Policy and Economics emphasizes an interdisciplinary approach to research and analysis to promote health and value in health care delivery and to support evidence-based health policy. Mr. Schaeffer also served as President and CEO of Group Health, Inc. of Minnesota, a staff model HMO. He also served as EVP and COO of the Student Loan Marketing Association, the national secondary market for student loans and earlier was a Vice President of Citibank and a consultant specializing in design and installation of large scale financial and management information systems.
In the federal government, he served as Administrator of the Health Care Financing Administration (now CMS) and was responsible for the U.S. Medicare and Medicaid programs. He was also the Assistant Secretary for Management and Budget of the federal Department of Health and Human Services. Previously, Mr. Schaeffer was Director of the Bureau of the Budget for the State of Illinois and also served as Chairman of the Illinois Capital Development Board and as Deputy Director for Management, Illinois Department of Mental Health and Developmental Disabilities.
Mr. Schaeffer is active on the boards of numerous businesses, philanthropic and professional organizations. He was awarded a Doctor of Humane Letters (Hon) from USC and received the inaugural USC Sol Price Award for his lifetime achievements as a business leader, policy expert and philanthropist. He was the Regent’s Lecturer at the University of California at Berkeley, a Gilbert Fellow at Princeton, and a Williams Fellow at RAND. He is a member of the National Academy of Medicine (NAM) of the National Academies. Mr. Schaeffer is a graduate of Princeton University.
© 2017 Vesey Street Capital Partners. All Rights Reserved.
Site Designed & Developed by Altastreet